Brown University

Psychopharmacological Treatment in Very Young Children with Severe Psychopathology: A Descriptive Study of Use and Adverse Effects

Description

Abstract:
Objectives: Psychotropic medication prescription rates for preschool age children are steadily increasing, despite underrepresentation of this age group in literature and the higher risk of adverse drug events (AE). A previous Bradley Hospital Pediatric Partial Hospital Program study found that fluoxetine was the most frequently AE-associated antidepressant (41.2%), followed by stimulants (methylphenidate: 22.7%; mixed amphetamine salts: 21.4%). This follow-up study aimed 1) to describe psychotropic medication use in this early childhood partial hospital program and 2) to characterize parent-reported AE of antidepressants and antipsychotics. Methods: Participants were 172 children (131 males; age 3 to 7 years) admitted to the Pediatric Partial Hospital Program for severe emotional and behavioral problems as indicated by Child Behavior Checklist (CBCL) scores significantly above the clinical cutoff (71.3 ± 9.7 [1.5-5 years], 70.5 ± 7.3 [6-18 years]). A medication tracking form was completed for each participant by a psychiatric nurse and reviewed by the program psychiatrist, documenting medication changes over the course of admission. A retrospective chart review was conducted to document parent-reported AE. Results: Most participants (78%) were prescribed psychiatric medications, most frequently 1) alpha-agonists (58%); 2) antidepressants (46%); and 3) atypical antipsychotics (25%). Fluoxetine was the most frequently AE-associated antidepressant (40%), and risperidone was the only AE-associated antipsychotic (21%). Increased impulsivity was the most frequently reported AE for both antidepressants (44%) and risperidone (29%). Once AE were identified, antidepressants and risperidone were frequently stopped (89%; 57%). Conclusions: This study is among the first to address AE of frequently prescribed antidepressants and antipsychotics in a preschool age children with severe psychopathology. The results support previous findings on AE in this vulnerable population and have important implications for psychotropic medication management. We plan to pilot a structured AE monitoring form to compare structured and spontaneous AE reporting, and predict that the form will capture AE more frequently.
Notes:
Scholarly concentration: Non-Scholarly Concentrator

Access Conditions

Use and Reproduction
All rights reserved

Citation

Lee, Erica, Davis, Thamara, Mernick, Lauren, et al., "Psychopharmacological Treatment in Very Young Children with Severe Psychopathology: A Descriptive Study of Use and Adverse Effects" (2018). Warren Alpert Medical School Academic Symposium. Brown Digital Repository. Brown University Library. https://repository.library.brown.edu/studio/item/bdr:833877/

Relations

Collection:

  • Warren Alpert Medical School Academic Symposium

    The Warren Alpert Medical School Academic Symposium is an annual event at Warren Alpert Medical School of Brown University that provides Year II medical students a venue to present their summer research in a poster format. Participation in the Symposium …
    ...